Bain Capital exits Emcure Pharma after selling remaining stake, ends 12-year bet
Investment firm Bain Capital on Thursday (June 25) exited pharmaceutical company Emcure Pharmaceuticals Ltd after selling its remaining stake of around 1%, marking the completion of its full exit and ending a 12-year investment in the company. The equity firm had acquired a 13% stake in Emcure Pharmaceuticals from global investment firm Blackstone in December…
